Bayer Prolactin Receptor Antibody For Male And Female Pattern Hair Loss

RolfLeeBuckler

Established Member
My Regimen
Reaction score
928
产业基地启航!北大分子医学南京转化研究院产业发展基地正式启用 - 园区要闻 - 南京生物医药谷 (njbpv.cn)

1637572858261.png


19-10-2021
HopeMedicine is an innovative biopharmaceutical company based on Professor Xiao Ruiping and his team from the School of Future Technology of Peking University, based on decades of research results in the field of translational medicine. At present, the company has completed the B round of financing, signed a global exclusive license agreement with Bayer for the development and industrialization of the monoclonal antibody HMI-115 targeting the prolactin receptor (PRLR), and is developing and industrializing multiple indications worldwide change. This antibody has the function of promoting hair growth and has a therapeutic effect on hair loss. It has shown excellent characteristics in animal models and human safety, and has obtained the approval of the US FDA Phase II clinical trial. In the near future, the US Phase II clinical trial will be launched. The patient was enrolled. In addition, Herqirui has also carried out the R&D and industrialization of more high-end innovative drugs through the dual-drive model of license-in (authorized introduction) and independent research and development.

--

SOOOO they will start Phase II clinical trial for HMI-115(hair growth) now in the US ;) :)
 

Pigeon

Senior Member
My Regimen
Reaction score
5,127
产业基地启航!北大分子医学南京转化研究院产业发展基地正式启用 - 园区要闻 - 南京生物医药谷 (njbpv.cn)

View attachment 172955

19-10-2021
HopeMedicine is an innovative biopharmaceutical company based on Professor Xiao Ruiping and his team from the School of Future Technology of Peking University, based on decades of research results in the field of translational medicine. At present, the company has completed the B round of financing, signed a global exclusive license agreement with Bayer for the development and industrialization of the monoclonal antibody HMI-115 targeting the prolactin receptor (PRLR), and is developing and industrializing multiple indications worldwide change. This antibody has the function of promoting hair growth and has a therapeutic effect on hair loss. It has shown excellent characteristics in animal models and human safety, and has obtained the approval of the US FDA Phase II clinical trial. In the near future, the US Phase II clinical trial will be launched. The patient was enrolled. In addition, Herqirui has also carried out the R&D and industrialization of more high-end innovative drugs through the dual-drive model of license-in (authorized introduction) and independent research and development.

--

SOOOO they will start Phase II clinical trial for HMI-115(hair growth) now in the US ;) :)
Fcking nice!
 

pegasus2

Senior Member
My Regimen
Reaction score
4,435
If you only need 1 hair transplant procedure then I'd just get that done instead of cancelling and hoping on something else that maybe at best is coming in 2024.

But for me hair transplant is not an option. If it was I'd go get it done now.
Exactly. If a hair transplant will cure you then why not? If you have diffuse hair loss is a different story
 

pegasus2

Senior Member
My Regimen
Reaction score
4,435
产业基地启航!北大分子医学南京转化研究院产业发展基地正式启用 - 园区要闻 - 南京生物医药谷 (njbpv.cn)

View attachment 172955

19-10-2021
HopeMedicine is an innovative biopharmaceutical company based on Professor Xiao Ruiping and his team from the School of Future Technology of Peking University, based on decades of research results in the field of translational medicine. At present, the company has completed the B round of financing, signed a global exclusive license agreement with Bayer for the development and industrialization of the monoclonal antibody HMI-115 targeting the prolactin receptor (PRLR), and is developing and industrializing multiple indications worldwide change. This antibody has the function of promoting hair growth and has a therapeutic effect on hair loss. It has shown excellent characteristics in animal models and human safety, and has obtained the approval of the US FDA Phase II clinical trial. In the near future, the US Phase II clinical trial will be launched. The patient was enrolled. In addition, Herqirui has also carried out the R&D and industrialization of more high-end innovative drugs through the dual-drive model of license-in (authorized introduction) and independent research and development.

--

SOOOO they will start Phase II clinical trial for HMI-115(hair growth) now in the US ;) :)
With translations you have to be careful. It isn't necessarily the hair loss trial they are referring to regarding FDA approval. This article isn't specific to hair loss even though it mentions it, it's about the company broadly so it could be referring to the endo trial, and probably is.
 

Jackshtbro

Member
My Regimen
Reaction score
44
With translations you have to be careful. It isn't necessarily the hair loss trial they are referring to regarding FDA approval. This article isn't specific to hair loss even though it mentions it, it's about the company broadly so it could be referring to the endo trial, and probably is.
I don't know man, seems legit to me. Bet their first patient has already done his second injection by now o_O
 

Dimitri001

Experienced Member
My Regimen
Reaction score
297
产业基地启航!北大分子医学南京转化研究院产业发展基地正式启用 - 园区要闻 - 南京生物医药谷 (njbpv.cn)

View attachment 172955

19-10-2021
HopeMedicine is an innovative biopharmaceutical company based on Professor Xiao Ruiping and his team from the School of Future Technology of Peking University, based on decades of research results in the field of translational medicine. At present, the company has completed the B round of financing, signed a global exclusive license agreement with Bayer for the development and industrialization of the monoclonal antibody HMI-115 targeting the prolactin receptor (PRLR), and is developing and industrializing multiple indications worldwide change. This antibody has the function of promoting hair growth and has a therapeutic effect on hair loss. It has shown excellent characteristics in animal models and human safety, and has obtained the approval of the US FDA Phase II clinical trial. In the near future, the US Phase II clinical trial will be launched. The patient was enrolled. In addition, Herqirui has also carried out the R&D and industrialization of more high-end innovative drugs through the dual-drive model of license-in (authorized introduction) and independent research and development.

--

SOOOO they will start Phase II clinical trial for HMI-115(hair growth) now in the US ;) :)
Thanks for keeping us up to date with the Chinese sources!
 

surfer9

Established Member
My Regimen
Reaction score
71
Just wondering.....do the trials being held in the U.S.A benefit us in anyway? is this one of the best countries we'd wish the trials to be held in?, if so, why?
 

trialAcc

Senior Member
My Regimen
Reaction score
1,414
Just wondering.....do the trials being held in the U.S.A benefit us in anyway? is this one of the best countries we'd wish the trials to be held in?, if so, why?
US trials are typically the most "legit". The FDA is pretty strict on drug approvals and probably wont accept Chinese trials for drug approvals in the USA.

Most people would question drugs that only have Chinese approval due to lower safety standards and potential for false trial data.
 

surfer9

Established Member
My Regimen
Reaction score
71
So...

We have something which has shown good safety and good hair growth even in slick bald monkeys...

Someone said these monkeys cost a lot to test on? it's rare to test on these monkeys? if so, is that because of the expense or drugs are only tested on them when they have huge potential?

We have a license agreement with HOPE Medicine, is this a huge indication of the confidence they have in this potential 'cure'? or is it normal for companies to sign these types of agreements at this stage?

Basically what I am asking is.... does all the above point to this likely being a success in helping a lot of humans get back a lot of their hair?

Is it pretty unique/rare in this world to have all these boxes ticked?
 

hmmmmmmmm

Established Member
My Regimen
Reaction score
92
If you only need 1 hair transplant procedure then I'd just get that done instead of cancelling and hoping on something else that maybe at best is coming in 2024.

But for me hair transplant is not an option. If it was I'd go get it done now.
Yes, that was the crux of my very first post in this thread.

and 2024 is very questionable to me as a timeframe because, as I said earlier, I don't see any strong reason to believe that it will even be past phase II recruitment for Androgenetic Alopecia in the next couple years

instead I see a bunch of signals that it won't be (despite being essentially guaranteed to pass phase I in men, they chose to trial in women only?)

and IMO it's not reasonable to have the 100% certainty that this will be "the" cure, because of very obvious red flags and gaps in the available information.

I hope I'm wrong about all that. I hope it works so I can get it too
 

pegasus2

Senior Member
My Regimen
Reaction score
4,435
Is there a chance it will already be on the market by 2024?
Let's assume they get approval for the trial and start recruiting by the end of the year. That puts them at least 3 months into 2022 before they are fully enrolled, at least 9 months into 2022 before the end of the trial, then at least 10 months into 2022 for data analysis. Let's say best case scenario they can apply for a pivotal trial at the start of 2023. Let's say 3 months best case before they get the green light, another 5 months+ to recruit and one year for the trial. That puts us 8 months into 2024. A couple months to prepare their application with the FDA. Best case scenario puts approval at q1 2025. It is realistic to say it could be available in 2026 assuming the trials go well.
 

RolfLeeBuckler

Established Member
My Regimen
Reaction score
928
Let's assume they get approval for the trial and start recruiting by the end of the year. That puts them at least 3 months into 2022 before they are fully enrolled, at least 9 months into 2022 before the end of the trial, then at least 10 months into 2022 for data analysis. Let's say best case scenario they can apply for a pivotal trial at the start of 2023. Let's say 3 months best case before they get the green light, another 5 months+ to recruit and one year for the trial. That puts us 8 months into 2024. A couple months to prepare their application with the FDA. Best case scenario puts approval at q1 2025. It is realistic to say it could be available in 2026 assuming the trials go well.

what do you mean When will they start the trial in Europe/Germany? If they start in US in december how long they will wait until starting in Europe?
 

surfer9

Established Member
My Regimen
Reaction score
71
Let's assume they get approval for the trial and start recruiting by the end of the year. That puts them at least 3 months into 2022 before they are fully enrolled, at least 9 months into 2022 before the end of the trial, then at least 10 months into 2022 for data analysis. Let's say best case scenario they can apply for a pivotal trial at the start of 2023. Let's say 3 months best case before they get the green light, another 5 months+ to recruit and one year for the trial. That puts us 8 months into 2024. A couple months to prepare their application with the FDA. Best case scenario puts approval at q1 2025. It is realistic to say it could be available in 2026 assuming the trials go well.

Didn't that Chinese article that someone translated say the patients were enrolled......


This antibody has the function of promoting hair growth and has a therapeutic effect on hair loss. It has shown excellent characteristics in animal models and human safety, and has obtained the approval of the US FDA Phase II clinical trial. In the near future, the US Phase II clinical trial will be launched. The patient was enrolled.
 

Dimitri001

Experienced Member
My Regimen
Reaction score
297
Let's assume they get approval for the trial and start recruiting by the end of the year. That puts them at least 3 months into 2022 before they are fully enrolled, at least 9 months into 2022 before the end of the trial, then at least 10 months into 2022 for data analysis. Let's say best case scenario they can apply for a pivotal trial at the start of 2023. Let's say 3 months best case before they get the green light, another 5 months+ to recruit and one year for the trial. That puts us 8 months into 2024. A couple months to prepare their application with the FDA. Best case scenario puts approval at q1 2025. It is realistic to say it could be available in 2026 assuming the trials go well.
In other words, it's a long way off and even when it comes it might be priced out of the reach of some of us, so we'd be smart to focus on experimenting with SMI-6 to find a concentration/frequency that works or on other PRLR antagonists or other methods of attacking the PRL angle.
 

Janko

Established Member
My Regimen
Reaction score
1,192
Let's assume they get approval for the trial and start recruiting by the end of the year. That puts them at least 3 months into 2022 before they are fully enrolled, at least 9 months into 2022 before the end of the trial, then at least 10 months into 2022 for data analysis. Let's say best case scenario they can apply for a pivotal trial at the start of 2023. Let's say 3 months best case before they get the green light, another 5 months+ to recruit and one year for the trial. That puts us 8 months into 2024. A couple months to prepare their application with the FDA. Best case scenario puts approval at q1 2025. It is realistic to say it could be available in 2026 assuming the trials go well.
If it will show awesome results after phase 2 I am sure it will get available in China. Also the black market would do its magic. Honestly, if it would come out in China and be really effective. I would fuckin swear loyality to chinese regime, sing songs about their communism anything. If that would not work, I would do plan B:
40d.jpg
 

surfer9

Established Member
My Regimen
Reaction score
71
I wish I could inject something into my scalp now and have full head of hair within months.....

I'd be walking around everywhere with a big smile on my face, just walking past people.... wherever most hot ladies are.....
 

jan_miezda

Banned
My Regimen
Reaction score
297
If it will show awesome results after phase 2 I am sure it will get available in China. Also the black market would do its magic. Honestly, if it would come out in China and be really effective. I would fuckin swear loyality to chinese regime, sing songs about their communism anything. If that would not work, I would do plan B:View attachment 172995
If it gets approved for endo then we will have a better ability/information about accessing it
 
Top